Interleukin 17 Rs2275913 And Rs763780 Gene Polymorphisms And Women'S Cancer Risk In Chinese Population: A Systemic Review And Meta-Analysis

Tao Li,Xiyan Mu,Ce Bian,Fan Yang,Shengtao Zhou,An Tong,Heng Zheng,Xia Zhao
2016-01-01
Abstract:The aim of this study was to evaluate interleukin 17 (IL-17) rs2275913 and rs763780 gene polymorphisms in women's cancer risk of Chinese population by meta-analysis. A comprehensive electronic search was conducted in PubMed, Weipu, Medline (Ovid), Embase, Wanfang and CNKI. The pooled ORs were performed using the Revman 5.2 softerware. 5 articles including 9 case-control studies analyzing cervical cancer, breast cancer and ovarian cancer were included. The results showed significant association between IL-17 rs2275913 polymorphisms and the risk of women's cancer (AA vs. AG+GG: overall OR = 1.66, 95% CI = 1.21-2.27; AA+AG vs. GG: overall OR = 1.38, 95% CI = 1.19-1.60; AA vs. GG: overall OR = 1.93, 95% CI = 1.54-2.42; A vs. G: overall OR = 1.35, 95% CI = 1.22-1.50). No association was found in rs763780 gene polymorphisms with women's cancer risk (CC vs. CT+TT: overall OR = 1.33, 95% CI = 0.92-1.86; CC+CT vs. TT: overall OR = 1.54, 95% CI = 0.44-5.36; CT vs. CC+TT: overall OR = 1.06, 95% CI = 0.89-1.26; CC vs. TT: overall OR = 1.37, 95% CI = 0.94-1.99; C vs. T: overall OR = 1.13, 95% CI = 0.98-1.30). The subgroup results on cervical cancer were consistent with those of overall analysis. This meta-analysis suggested that IL-17 rs2275913 instead of rs763780 polymorphisms were associated with the risks of women's cancer in Chinese people. Further studies are needed to validate the conclusion.
What problem does this paper attempt to address?